Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns
Business
Archived
•
November 21, 2025
•
Source: https://finance.yahoo.com/rss/topstories - Read Original
"Because adventure is exploring the unknown"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"What you put in is not always what you get out."
"We build AI or anything ICST"